{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:27:09Z","timestamp":1777616829109,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.vaccine.2017.05.046","type":"journal-article","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T23:01:39Z","timestamp":1499209299000},"page":"4430-4436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Comparative efficacy and toxicity of two vaccine candidates against Sporothrix schenckii using either Montanide\u2122 Pet Gel A or aluminum hydroxide adjuvants in mice"],"prefix":"10.1016","volume":"35","author":[{"given":"Deivys Leandro","family":"Portuondo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Batista-Duharte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Souza","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cleverton Roberto","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Quinello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damiana","family":"T\u00e9llez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luiza","family":"de Aguiar Loesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iracilda Zeppone","family":"Carlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.05.046_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/mmy\/myu062","article-title":"Global epidemiology of sporotrichosis","volume":"53","author":"Chakrabarti","year":"2015","journal-title":"Med Mycol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0010","series-title":"Sporotrichosis","first-page":"1","article-title":"Sporotrichosis: an emergent disease","author":"Carlos","year":"2015"},{"key":"10.1016\/j.vaccine.2017.05.046_b0015","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1099\/mic.0.081794-0","article-title":"Sporothrix schenckii complex biology: environment and fungal pathogenicity","volume":"160","author":"T\u00e9llez","year":"2014","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2017.05.046_b0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2217\/fmb.10.157","article-title":"Sporothrix schenckii complex and sporotrichosis, an emerging health problem","volume":"6","author":"L\u00f3pez-Romero","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/mmy\/myu061","article-title":"Feline sporotrichosis: epidemiological and clinical aspects","volume":"53","author":"Gremi\u00e3o","year":"2015","journal-title":"Med Mycol"},{"issue":"6","key":"10.1016\/j.vaccine.2017.05.046_b0030","doi-asserted-by":"crossref","first-page":"e2281","DOI":"10.1371\/journal.pntd.0002281","article-title":"Phylogenetic analysis reveals a high prevalence of Sporothrix brasiliensis in feline sporotrichosis outbreaks","volume":"7","author":"Rodrigues","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.05.046_b0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s15010-015-0746-1","article-title":"The impact of sporotrichosis in HIV-infected patients: a systematic review","volume":"43","author":"Moreira","year":"2015","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2017.05.046_b0040","series-title":"Sporotrichosis","first-page":"147","article-title":"Therapeutic and prophylactic tools for sporotrichosis: current strategies and future tendencies","author":"Batista-Duharte","year":"2015"},{"key":"10.1016\/j.vaccine.2017.05.046_b0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.intimp.2016.09.008","article-title":"Antifungal and immunomodulatory activity of a novel cochleate for amphotericin B delivery against Sporothrix schenckii","volume":"40","author":"Batista-Duharte","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00442774","article-title":"Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease","volume":"117","author":"Carlos","year":"1992","journal-title":"Mycopathologia"},{"key":"10.1016\/j.vaccine.2017.05.046_b0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11046-012-9523-1","article-title":"Immune response against Sporothrix schenckii in TLR-4-deficient mice","volume":"174","author":"Sass\u00e1","year":"2012","journal-title":"Mycopathologia"},{"key":"10.1016\/j.vaccine.2017.05.046_b0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/08820139.2012.719982","article-title":"Role of TLR-2 and fungal surface antigens on innate immune response against Sporothrix schenckii","volume":"42","author":"Negrini","year":"2013","journal-title":"Immunol Investigat"},{"key":"10.1016\/j.vaccine.2017.05.046_b0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11046-014-9810-0","article-title":"Involvement of major components from Sporothrix schenckii cell wall in the caspase-1 activation, nitric oxide and cytokines production during experimental sporotrichosis","volume":"179","author":"Gon\u00e7alves","year":"2015","journal-title":"Mycopathologia"},{"key":"10.1016\/j.vaccine.2017.05.046_b0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11046-015-9966-2","article-title":"Response of cytokines and hydrogen peroxide to Sporothrix schenckii exoantigen in systemic experimental infection","volume":"181","author":"Maia","year":"2016","journal-title":"Mycopathologia"},{"key":"10.1016\/j.vaccine.2017.05.046_b0075","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.imbio.2015.02.009","article-title":"Optimal clearance of Sporothrix schenckii requires an intact Th17 response in a mouse model of systemic infection","volume":"220","author":"Ferreira","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2017.05.046_b0080","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.imbio.2012.04.006","article-title":"Dendritic cell are able to differentially recognize Sporothrix schenckii antigens and promote Th1\/Th17 response in vitro","volume":"217","author":"Verdan","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2017.05.046_b0085","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/08820139.2013.879174","article-title":"Influence of TLR-2 in the immune response in the infection induced by fungus Sporothrix schenckii","volume":"43","author":"Negrini","year":"2014","journal-title":"Immunol Investigat"},{"key":"10.1016\/j.vaccine.2017.05.046_b0090","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.imbio.2015.10.005","article-title":"A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection","volume":"221","author":"Portuondo","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.vaccine.2017.05.046_b0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0264-410X(93)90190-9","article-title":"Adjuvants\u2014a balance between toxicity and adjuvanticity","volume":"11","author":"Gupta","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.046_b0100","first-page":"5391","article-title":"Postvaccinal sarcomas in the cat: epidemiology and electron probe microanalytical identification of aluminum","volume":"52","author":"Hendrick","year":"1992","journal-title":"Can Res"},{"key":"10.1016\/j.vaccine.2017.05.046_b0105","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2460\/javma.1993.203.03.396","article-title":"Epidemiologic evidence for a causal relation between vaccination and fibrosarcoma tumorigenesis in cats","volume":"20","author":"Kass","year":"1993","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2017.05.046_b0110","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.intimp.2013.07.025","article-title":"An approach to local immunotoxicity induced by adjuvanted vaccines","volume":"17","author":"Batista-Duharte","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0115","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.provac.2011.07.015","article-title":"Adjuvant formulation for companion animals vaccines","volume":"4","author":"Deville","year":"2011","journal-title":"Proc Vaccinol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12917-014-0269-5","article-title":"Feline sporotrichosis due to Sporothrix brasiliensis: an emerging animal infection in S\u00e3o Paulo Brazil","volume":"10","author":"Montenegro","year":"2014","journal-title":"BMC Veterinary Res"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.046_b0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jps.22759","article-title":"Aluminum adjuvant dose guidelines in vaccine formulation for preclinical evaluations","volume":"101","author":"Vecchi","year":"2012","journal-title":"J Pharma Sci"},{"key":"10.1016\/j.vaccine.2017.05.046_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2017.05.046_b0135","doi-asserted-by":"crossref","first-page":"B14","DOI":"10.1016\/j.vaccine.2015.01.088","article-title":"New generation adjuvants\u2013from empiricism to rational design","volume":"33","author":"O\u2019Hagan","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.046_b0140","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1016\/j.vaccine.2015.04.099","article-title":"Molecular signatures of vaccine adjuvants","volume":"33","author":"Olafsdottir","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.046_b0145","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.intimp.2014.02.033","article-title":"Systemic immunotoxicity reactions induced by adjuvanted vaccines","volume":"20","author":"Batista-Duharte","year":"2014","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/mmy\/myu045","article-title":"Adjuvants and delivery systems for antifungal vaccines: current state and future developments","volume":"53","author":"Portuondo","year":"2015","journal-title":"Med Mycol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0155","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.vetimm.2013.12.003","volume":"157","author":"Cauchard","year":"2014","journal-title":"Veterinary Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0160","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1348-0421.1994.tb01820.x","article-title":"Relationship between hemolytic activity and adsorption capacity of aluminum hydroxide and calcium phosphate as immunological adjuvants for biologicals","volume":"38","author":"Kato","year":"1994","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0165","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/1091581816672187","article-title":"The Hen\u2019s Egg test on chorioallantoic membrane an alternative assay for the assessment of the irritating effect of vaccine adjuvants","volume":"35","author":"Batista-Duharte","year":"2016","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0170","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.femsim.2004.08.004","article-title":"Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis","volume":"43","author":"Nascimento","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0175","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1002\/eji.200838513","article-title":"Passive immunization with monoclonal antibody against a 70-kDa putative adhesin of Sporothrix schenckii induces protection in murine sporotrichosis","volume":"38","author":"Nascimento","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0180","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/mmy\/myu049","article-title":"Therapeutic vaccine using a monoclonal antibody against a 70-kDa glycoprotein in mice infected with highly virulent Sporothrix schenckii and Sporothrix brasiliensis","volume":"53","author":"de Almeida","year":"2015","journal-title":"Med Mycol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0185","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1365-3083.2011.02636.x","article-title":"Antibodies against Sporothrix schenckii enhance TNF-\u03b1 production and killing by macrophages","volume":"75","author":"de Lima Franco","year":"2012","journal-title":"Scandinavian J Immunol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0190","first-page":"52","article-title":"Immune response induced by an immunodominant 60 kDa glycoprotein of the cell wall of Sporothrix schenckii in two mice strains with experimental sporotrichosis","volume":"6","author":"Alba-Fierro","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.vaccine.2017.05.046_b0195","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.4049\/jimmunol.172.9.5269","article-title":"IgG2a-mediated enhancement of antibody and T cell responses and its relation to inhibitory and activating Fc\u03b3 receptors","volume":"172","author":"Getahun","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.molimm.2014.06.010","article-title":"How antibodies use complement to regulate antibody responses","volume":"61","author":"S\u00f6rman","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0205","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/eji.1830250329","article-title":"Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo","volume":"25","author":"Germann","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0210","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1128\/IAI.71.12.6915-6920.2003","article-title":"Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3","volume":"71","author":"Lefeber","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.046_b0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11046-005-0142-y","article-title":"Influence of Th1\/Th2 cytokines and nitric oxide in murine systemic infection induced by Sporothrix schenckii","volume":"16","author":"Maia","year":"2006","journal-title":"Mycopathologia"},{"key":"10.1016\/j.vaccine.2017.05.046_b0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11046-013-9663-y","article-title":"The predominance of alternatively activated macrophages following challenge with cell wall peptide-polysaccharide after prior infection with Sporothrix schenckii","volume":"176","author":"Alegranci","year":"2013","journal-title":"Mycopathologia"},{"key":"10.1016\/j.vaccine.2017.05.046_b0225","first-page":"261","article-title":"Molecular diversity of macrophages in allergic reaction: comparison between the allergenic modes; Th1-and-Th2-derived immune conditions","volume":"14","author":"Bagheri","year":"2015","journal-title":"Iranian J Allergy, Asthma Immunol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0230","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.provac.2010.03.003","article-title":"Microgel particulate adjuvant: characterization and mechanisms of action","volume":"2","author":"Vialle","year":"2010","journal-title":"Proc Vaccinol"},{"key":"10.1016\/j.vaccine.2017.05.046_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/212308","article-title":"Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex","author":"Almeida-Paes","year":"2015","journal-title":"BioMed Res Int"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17306825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T07:09:16Z","timestamp":1719299356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17306825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":47,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0264410X17306825"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.046","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and toxicity of two vaccine candidates against Sporothrix schenckii using either Montanide\u2122 Pet Gel A or aluminum hydroxide adjuvants in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}